|
|
 |
Guidance for behavioural treatment providers: NIDA
|
The National Institute on Drug Abuse (NIDA) is committed to promoting research activities that result in improved drug abuse treatment and reductions in HIV/AIDS risk behavior in drug-dependent individuals.
The purpose of this initiative is to support studies for developing and testing novel, creative approaches to clinical training and supervision that will enhance community treatment providers' knowledge and skills to administer behavioral treatments with some evidence of efficacy for drug abuse or interventions for HIV/AIDS risk reduction among in-treatment drug abusers. This request for applications (RFA) especially encourages theory-driven approaches to the development of novel training and supervision methods, i.e., approaches that apply knowledge derived from cognitive neuroscience, psychology, medical education, and other fields of science to training and supervision.
Sponsor:Department of Health and Human Services (DHHS); National Institutes of Health (NIH) and National Institute on Drug Abuse (NIDA).
Sponsor Reference Number:DA-03-005.
Deadline: December 16, 2002.
Eligibility: Applications may be submitted by domestic or foreign, for-profit or nonprofit organizations and public or private institutions, such as universities, colleges, hospitals, and laboratories; units of state and local governments; eligible agencies of the federal government; and faith-based or community-based organizations.
Cecelia L. McNamara, Ph.D.
National Institute on Drug Abuse, Division of Treatment Research and Development, Behavioral Treatment Development Branch,6001 Executive Boulevard, MSC 9551, Bethesda, Maryland, 20892-9551, USA. Telephone: +1 (301) 402-1488; Fax: +1 (301) 443-6814; Email: [email protected]
URL for further information: http://grants1.nih.gov/grants/guide/rfa-files/RFA-DA-03-005.html |
| Was this article helpful to you? |
 ?0%???? ?0%
|
|
Back
|
|
|
|
